MAPT and Alzheimer disease: Since CAA type 1 has been directly associated with AD severity, including tau pathology, age, and with ApoE-ε4 allele frequency, the predominance of type 2 CAA in iCJD is not surprising given the relatively younger age and short duration of this condition [52, 62].